-
DROPERIDOL (INAPSINE)
Class
Sedative
-
DROPERIDOL (INAPSINE)
Mechanism of Action
Exact mechanism of action is unknown. Neurolepticsimilar to haloperidol; reduces anxiety and produces amental state of detachment and indifference; hasantiemetic and antinauseant properties. Droperidolproduces marked tranquilization and sedation.
-
DROPERIDOL (INAPSINE)
Indications
Chemical restraint requiring rapid tranquilization
-
DROPERIDOL (INAPSINE)
Contraindications
Hypotension, prolonged QT
-
DROPERIDOL (INAPSINE)
Dosage
- 14-60 y/o: 2.5-5 mg IM or IV (may be combined with 2 mg midazolam insame syringe for increased sedation), may be repeated onceas needed.
- Over 60 y/o: 2.5 mg (with or without midazolam). Not recommended asfirst line anti-N&V med because of “black box” warning
-
HALOPERIDOL (HALDOL)
Class:
Sedative, neuroleptic
-
HALOPERIDOL (HALDOL)
Mechanism of Action
Blocks dopamine receptors in brain; produces markedtranquilization and sedation
-
HALOPERIDOL (HALDOL)
Indications
Chemical restraint requiring rapid tranquilization
-
HALOPERIDOL (HALDOL)
Contraindications
Hypotension, prolonged QT, patients taking lithium
-
HALOPERIDOL (HALDOL)
Dosage
2-5 mg IM (may be combined midazolam)
-
PROMETHAZINE (PHENERGAN)
Class:
Antihistamine and Antiemetic
-
PROMETHAZINE (PHENERGAN)
Mechanism of Action:
Antagonizes H1 receptors. A phenothiazine derivativewith potent antihistamine and anticholinergic properties.It also possesses sedative and antiemetic properties.
-
PROMETHAZINE (PHENERGAN)
Indications
Nausea and vomiting, motion sickness, and sedation (to potentiatethe effects of analgesics)
-
PROMETHAZINE (PHENERGAN)
Contraindications
Coma, those who have received large amounts ofdepressants, nursing mother, neonate
-
PROMETHAZINE (PHENERGAN)
Dosage
- PROMETHAZINE (PHENERGAN)
- Contraindications
|
|
